Literature DB >> 15870288

Energy homeostasis and gastrointestinal endocrine differentiation do not require the anorectic hormone peptide YY.

Susan Schonhoff1, Laurie Baggio, Christelle Ratineau, Subir K Ray, Jill Lindner, Mark A Magnuson, Daniel J Drucker, Andrew B Leiter.   

Abstract

The gastrointestinal hormone peptide YY is a potent inhibitor of food intake and is expressed early during differentiation of intestinal and pancreatic endocrine cells. In order to better understand the role of peptide YY in energy homeostasis and development, we created mice with a targeted deletion of the peptide YY gene. All intestinal and pancreatic endocrine cells developed normally in the absence of peptide YY with the exception of pancreatic polypeptide (PP) cells, indicating that peptide YY expression was not required for terminal differentiation. We used recombination-based cell lineage trace to determine if peptide YY cells were progenitors for gastrointestinal endocrine cells. Peptide YY(+) cells gave rise to all L-type enteroendocrine cells and to islet partial differential and PP cells. In the pancreas, approximately 40% of pancreatic alpha and rare beta cells arose from peptide YY(+) cells, suggesting that most beta cells and surprisingly the majority of alpha cells are not descendants of peptide YY(+)/glucagon-positive/insulin-positive cells that appear during early pancreagenesis. Despite the anorectic effects of exogenous peptide YY(3-36) following intraperitoneal administration, mice lacking peptide YY showed normal growth, food intake, energy expenditure, and responsiveness to peptide YY(3-36). These observations suggest that targeted disruption of the peptide YY gene does not perturb terminal endocrine cell differentiation or the control of food intake and energy homeostasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870288      PMCID: PMC1087718          DOI: 10.1128/MCB.25.10.4189-4199.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.

Authors:  M Lakso; J G Pichel; J R Gorman; B Sauer; Y Okamoto; E Lee; F W Alt; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Influence of meal composition on postprandial peripheral plasma concentrations of vasoactive peptides in man.

Authors:  U Pedersen-Bjergaard; U Høst; H Kelbaek; S Schifter; J F Rehfeld; J Faber; N J Christensen
Journal:  Scand J Clin Lab Invest       Date:  1996-10       Impact factor: 1.713

3.  F(ab) secondary antibodies: a general method for double immunolabeling with primary antisera from the same species. Efficiency control by chemiluminescence.

Authors:  A Negoescu; F Labat-Moleur; P Lorimier; L Lamarcq; C Guillermet; E Chambaz; E Brambilla
Journal:  J Histochem Cytochem       Date:  1994-03       Impact factor: 2.479

4.  Ablation of islet endocrine cells by targeted expression of hormone-promoter-driven toxigenes.

Authors:  P L Herrera; J Huarte; R Zufferey; A Nichols; B Mermillod; J Philippe; P Muniesa; F Sanvito; L Orci; J D Vassalli
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

5.  PYY in developing murine islet cells: comparisons to development of islet hormones, NPY, and BrdU incorporation.

Authors:  M Jackerott; A Oster; L I Larsson
Journal:  J Histochem Cytochem       Date:  1996-08       Impact factor: 2.479

6.  Saturable binding of circulating peptide YY in the dorsal vagal complex of rats.

Authors:  E J Hernandez; D C Whitcomb; S R Vigna; I L Taylor
Journal:  Am J Physiol       Date:  1994-03

7.  Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36.

Authors:  D Grandt; M Schimiczek; C Beglinger; P Layer; H Goebell; V E Eysselein; J R Reeve
Journal:  Regul Pept       Date:  1994-05-05

8.  Studies in transgenic mice reveal potential relationships between secretin-producing cells and other endocrine cell types.

Authors:  M J Lopez; B H Upchurch; G Rindi; A B Leiter
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

9.  Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV.

Authors:  R Mentlein; P Dahms; D Grandt; R Krüger
Journal:  Regul Pept       Date:  1993-12-10

10.  Peptide YY expression is an early event in colonic endocrine cell differentiation: evidence from normal and transgenic mice.

Authors:  B H Upchurch; B P Fung; G Rindi; A Ronco; A B Leiter
Journal:  Development       Date:  1996-04       Impact factor: 6.868

View more
  19 in total

Review 1.  Gut hormones and leptin: impact on energy control and changes after bariatric surgery--what the future holds.

Authors:  Konstantinos Michalakis; Carel le Roux
Journal:  Obes Surg       Date:  2012-10       Impact factor: 4.129

2.  NPY receptors as potential targets for anti-obesity drug development.

Authors:  Ernie Yulyaningsih; Lei Zhang; Herbert Herzog; Amanda Sainsbury
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

3.  Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells.

Authors:  Diego V Bohórquez; Rafiq A Shahid; Alan Erdmann; Alex M Kreger; Yu Wang; Nicole Calakos; Fan Wang; Rodger A Liddle
Journal:  J Clin Invest       Date:  2015-01-02       Impact factor: 14.808

4.  The Endocrine Pancreas: insights into development, differentiation and diabetes.

Authors:  Teresa L Mastracci; Lori Sussel
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-03-14

5.  Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity.

Authors:  D Boey; S Lin; T Karl; P Baldock; N Lee; R Enriquez; M Couzens; K Slack; R Dallmann; A Sainsbury; H Herzog
Journal:  Diabetologia       Date:  2006-04-21       Impact factor: 10.122

6.  GATA6 is required for proliferation, migration, secretory cell maturation, and gene expression in the mature mouse colon.

Authors:  Eva Beuling; Boaz E Aronson; Luc M D Tran; Kelly A Stapleton; Ellis N ter Horst; Laurens A T M Vissers; Michael P Verzi; Stephen D Krasinski
Journal:  Mol Cell Biol       Date:  2012-06-25       Impact factor: 4.272

Review 7.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

Review 8.  How and why do gastrointestinal peptides influence food intake?

Authors:  Stephen C Woods; Aaron A May-Zhang; Denovan P Begg
Journal:  Physiol Behav       Date:  2018-03-22

9.  PYY in the expanding pancreatic epithelium.

Authors:  Guoxun Liu; Sandrine Arnaud-Dabernat; Marcie R Kritzik; Ayse G Kayali; You-Qing Zhang; Nora Sarvetnick
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

10.  Notch signaling differentially regulates the cell fate of early endocrine precursor cells and their maturing descendants in the mouse pancreas and intestine.

Authors:  Hui Joyce Li; Archana Kapoor; Maryann Giel-Moloney; Guido Rindi; Andrew B Leiter
Journal:  Dev Biol       Date:  2012-09-01       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.